Bausch Health Companies Inc

Bausch Health Companies Inc

BHC

Get informed when a big investor buys or sells

+ Follow
Market Cap$2B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bausch Health Companies IncBausch Health Companies Inc-1.7-58%0.2-10.1
$13.85

Current Fair Value

179.9% upside

Undervalued by 179.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.00 Billion
Enterprise Value$21.50 Billion
Dividend Yield$- (-)
Earnings per Share$0.43
Beta0.42
Outstanding Shares372,800,000

Return

Return on Equity57.58%ROE
Return on Assets-4.84%
Return on Invested Capital10.60%

Valuation & Multiples

P/E Ratio-1.68P/E Ratio
PEG-0.07PEG
Price to Sales0.22Price to Sales
Price to Book Ratio-1.65Price to Book Ratio
Enterprise Value to Revenue2.5
Enterprise Value to EBIT10.16
Enterprise Value to Net Income-19
Total Debt to Enterprise0.97
Debt to Equity-10.1Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 29, 2026
EPS Estimate
$0.81
Average shareholder expectation
Revenue Estimate
$2.37 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 29, 2026
EPS Estimate
$0.96
Average shareholder expectation
Revenue Estimate
$2.62 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.9200 146.10%
Total Calls1,883,400 67.53%
Total Puts3,616,100 4.86%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %62.79% 0.73%
Total Invested$1.26B 23.02%
Investors Holding245 8.00%

ESG Score

No data

About Bausch Health Companies Inc

21,100 employees

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...